Concepedia

Sudthida Vasavanonda

SV

21

Publications

3K

Citations

19

H-Index

1990

Active since

Affiliations

Abbott Fund(Current)

Abbott (United Kingdom)

Abbott (United States)

Discovery Laboratories (United States)

Sudthida Vasavanonda is an author at Abbott Fund specializing in medicine, hiv, and drug discovery.

Top concepts

Publications per year

1990–2006

21

Publications

21

Ordered accumulation of mutations in HIV protease confers resistance to ritonavir

Akhteruzzaman Molla, Marina Korneyeva, Qing Gao et al. · Nature Medicine · 1996 · 766 citations

, , +10

ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans.

Dale J. Kempf, Kennan C. Marsh, Jon F. Denissen et al. · Proceedings of the National Academy of Sciences · 1995 · 551 citations · Full text

ABT-378, a Highly Potent Inhibitor of the Human Immunodeficiency Virus Protease

Hing L. Sham, Dale J. Kempf, Akhteruzammen Molla et al. · Antimicrobial Agents and Chemotherapy · 1998 · 468 citations · Full text

Structure-based, C2 symmetric inhibitors of HIV protease

Dale J. Kempf, Daniel W. Norbeck, LynnMarie Codacovi et al. · Journal of Medicinal Chemistry · 1990 · 211 citations · Full text

, , +19

Discovery of Ritonavir, a Potent Inhibitor of HIV Protease with High Oral Bioavailability and Clinical Efficacy

Dale J. Kempf, Hing L. Sham, Kennan C. Marsh et al. · Journal of Medicinal Chemistry · 1998 · 204 citations · Full text

, , +18

Rows per page

1–5 of 21